supplement interaction
33 interactions related to supplement interaction
calcium + zinc
Calcium can lower zinc absorption from the same meal, but results in people differ by setting. In one study, a 600 mg calcium carbonate supplement taken with a test meal halved zinc absorption from that meal, and in 18 postmenopausal women an extra 468 mg of calcium a day lowered net zinc absorption and balance by about 2 mg a day. In a later study of 10 women eating ordinary diets with about 700 or 1,800 mg of calcium a day, calcium did not change zinc absorption.
St. John's Wort + SSRI
St. John's Wort raises serotonin activity, and SSRI labels (including Zoloft, Prozac, Paxil, Celexa and Lexapro) list it among the products that increase the risk of serotonin syndrome, a potentially life-threatening reaction. It also speeds up CYP3A4 and the transporter P-glycoprotein, which may lower the levels of some antidepressants. Serotonin syndrome has been reported in older adults who combined antidepressants with the herb, so the advice is to avoid the combination.
vitamin d + vitamin k2
Vitamin D and vitamin K2 act synergistically on calcium metabolism: vitamin D increases calcium absorption while vitamin K2 activates osteocalcin and matrix Gla protein to direct calcium into bone and away from soft tissue. The main caution is for people taking warfarin.
tramadol + 5-htp
Tramadol blocks the reuptake of serotonin, and 5-HTP is a direct precursor that raises serotonin production in the brain. Stacking the two can push serotonin activity too high and trigger serotonin syndrome, a potentially life-threatening reaction.
curcumin + piperine
Piperine (black pepper extract) substantially increases how much curcumin your body absorbs.
mirtazapine + tryptophan
Mirtazapine is an antidepressant that enhances serotonin activity, and L-tryptophan is the amino acid the body turns into serotonin. The Remeron label lists tryptophan among the serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, particularly when treatment starts or the dose goes up. The warning rests on the label and the shared mechanism: no published case of serotonin syndrome from this exact pair was found.
losartan + potassium
Losartan blocks the angiotensin II receptor, lowering aldosterone and reducing the amount of potassium the kidneys excrete. Adding concentrated potassium supplements or potassium-based salt substitutes can push serum potassium toward the hyperkalemic range, which carries cardiac arrhythmia risk in people with kidney impairment, diabetes, or heart failure. Routine monotherapy raises measured potassium only modestly in people with healthy kidneys, but the safety margin narrows once supplements or other potassium-raising drugs are added.
lisinopril + potassium
Lisinopril blocks the renin-angiotensin-aldosterone system, lowering aldosterone and reducing the kidneys' ability to excrete potassium. Adding a potassium supplement or potassium-based salt substitute on top can push blood potassium into a dangerous range (hyperkalemia), especially in older adults or people with reduced kidney function.
paroxetine + tryptophan
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Paxil label says combining paroxetine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. The label for Brisdelle, a low-dose paroxetine, adds that headache, nausea, sweating and dizziness have been reported when tryptophan was given to people taking paroxetine and says the combination is not recommended. No published case of serotonin syndrome with this exact pair was found; the rating follows the labels and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.
metformin + vitamin b12
Long-term metformin use can reduce vitamin B12 absorption, sometimes enough to cause deficiency.
citalopram + tryptophan
Citalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Celexa label says the risk of serotonin syndrome, a potentially life-threatening reaction, is increased with other serotonergic drugs, and it names tryptophan in the same list as St. John's wort. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with escitalopram, sertraline, fluoxetine and venlafaxine.
tramadol + tryptophan
Tramadol is an opioid pain medicine that also blocks the reuptake of serotonin, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can add up and raise the risk of serotonin syndrome, a potentially life-threatening reaction. The tramadol label warns that serotonin syndrome has been reported with tramadol, particularly with drugs that affect serotonin, even at recommended doses; it does not name tryptophan, but FDA labels for antidepressants list tryptophan and tramadol side by side as serotonergic drugs. No published human study or case of this exact pair was found, so the rating rests on the label's class warning and the shared mechanism.
paroxetine + 5-htp
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Paxil label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with paroxetine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
citalopram + 5-htp
Citalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Celexa label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with citalopram and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
metformin + alpha-lipoic acid
Metformin and alpha-lipoic acid both lower blood glucose by independent routes, so their effects can be additive. The added effect is mild for most people, but matters more in those also taking insulin or a sulfonylurea, or who are elderly, thin, or on a beta-blocker.
amitriptyline + 5-htp
Amitriptyline slows the clearing of serotonin from nerve endings, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and raise the risk of serotonin syndrome. The amitriptyline label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic products that raise this risk; it does not name 5-HTP itself. No study or case report of amitriptyline plus 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with a different antidepressant, sertraline.
metformin + chromium
Chromium is sometimes taken to support blood sugar, and in theory it could add to metformin's glucose-lowering effect. In practice, trials disagree: a 2020 meta-analysis of trials in type 2 diabetes found lower fasting glucose and HbA1c, with very large differences between studies, while an earlier meta-analysis called the data in diabetes inconclusive. Because both are aimed at the same goal, it is worth flagging to your prescriber and watching for any signs of a low.
venlafaxine + 5-htp
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Effexor XR label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with venlafaxine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, an SSRI.
duloxetine + 5-htp
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Cymbalta label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with duloxetine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, an SSRI.
escitalopram + 5-htp
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Lexapro label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with escitalopram and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
fluvoxamine + 5-htp
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The fluvoxamine label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk and says it may enhance fluvoxamine's effects; it does not name 5-HTP itself. No case with fluvoxamine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
valsartan + spirulina
Spirulina lowered blood pressure modestly in randomized trials: a 2025 meta-analysis found drops of about 4.4 mmHg systolic and 2.8 mmHg diastolic, more clearly in people with high blood pressure. Taken with valsartan, the blood-pressure effects may add a little. No study has tested spirulina with valsartan or measured its effect on potassium in people taking valsartan. The Diovan label lists potassium supplements and other potassium-raising products as agents that may increase serum potassium, which matters most with kidney impairment or heart failure.
warfarin + coq10
Coenzyme Q10 (CoQ10) is chemically similar to vitamin K, and the warfarin label lists it among botanicals that may decrease warfarin's effect. Human evidence is mixed: case reports describe a weaker warfarin response that returned to normal after CoQ10 was stopped, but a randomized, placebo-controlled crossover trial in 24 patients on stable long-term warfarin found no change in the warfarin dose needed. A 171-patient observational study linked CoQ10 use with more self-reported bleeding, which is an association, not proof.
fluvoxamine + tryptophan
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The fluvoxamine label says the risk of serotonin syndrome, a potentially life-threatening reaction, is increased with other serotonergic drugs including tryptophan, and it gives tryptophan its own warning: it may enhance fluvoxamine's serotonin effects, and severe vomiting has been reported with the combination. In 30 depressed patients, fluvoxamine strengthened the body's hormone response to tryptophan given by vein, a sign of a stronger serotonin effect; no controlled study has measured how often harm occurs.
trazodone + 5-htp
Both trazodone and 5-HTP raise serotonin activity, but through different routes. Trazodone is a serotonin antagonist and reuptake inhibitor that keeps more serotonin in the synapse, while 5-HTP is a direct precursor that increases how much serotonin the body makes. Stacking the two adds up, and the trazodone label warns of serotonin syndrome when it is combined with other serotonergic drugs, including tryptophan, the precursor of 5-HTP.
amitriptyline + tryptophan
Amitriptyline is a tricyclic antidepressant that slows the clearing of serotonin from nerve endings, and L-tryptophan is the amino acid the body turns into serotonin. The amitriptyline label lists tryptophan among the serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, particularly when treatment starts or the dose goes up. The warning rests on the label and the shared mechanism: no published case of serotonin syndrome from this exact pair was found, and the few older human studies that gave the two together were small and did not measure safety.
trazodone + tryptophan
Trazodone raises serotonin activity, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The trazodone label lists tryptophan among serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, and its Medication Guide names tryptophan as an over-the-counter supplement to tell your healthcare provider about. No published case of serotonin syndrome with this pair was found. The only human reports are letters from 1986 to 1989, read by title only: two are titled as describing the combination as a treatment for aggressive behavior, and a 1989 letter is titled as reporting severe anorexia and possible psychosis or hypomania after it.
venlafaxine + tryptophan
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Effexor XR label says combining venlafaxine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with SSRI antidepressants such as sertraline and fluoxetine, whose labels list it the same way.
amlodipine + calcium
Amlodipine blocks calcium channels in artery walls, but it does not lower blood calcium, and no study has shown that calcium supplements weaken its effect. In the Women's Health Initiative trial of 36,282 postmenopausal women, 1,000 mg of calcium plus 400 IU of vitamin D3 daily for a median of 7 years did not change blood pressure, including in women with high blood pressure, though the trial did not report results for amlodipine users separately. Any interaction is theoretical.
ginseng + caffeine
Ginseng and caffeine are both mild stimulants, so combining them can additively increase alertness, jitteriness, palpitations, or insomnia in sensitive people, though the best evidence shows no meaningful cardiac signal from ginseng itself.
guarana + caffeine medications
Guarana seeds are an unusually concentrated source of caffeine, carrying several times the caffeine of coffee beans, and that caffeine adds directly to any caffeine-containing medication (such as Excedrin, Fioricet, Cafergot, Anacin, Esgic, NoDoz, or Vivarin). Because the caffeine is additive and easy to overlook, stacking guarana on top of these products can push total caffeine intake into a range linked to tachycardia, hypertension, jitteriness, GI upset, insomnia, and, in published case reports, serious cardiac arrhythmias.
duloxetine + tryptophan
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Cymbalta label says combining duloxetine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. No published case with only this pair was found; the rating follows the label warning and matches the rating for tryptophan with venlafaxine, the other SNRI, and with SSRIs such as sertraline and fluoxetine.
escitalopram + tryptophan
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Lexapro label says combining escitalopram with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. Its highlights say use with tryptophan is not recommended. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.
